Name: Maze Therapeutics, Inc. (MAZE) Balance Sheet
Creator: FinSpry

Maze Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Maze Therapeutics, Inc. (MAZE) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	196.81	29.16	99.92
Cash & Short-Term Investments	196.81	29.16	99.92
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	4.86	4.95	6.23
Total Current Assets	201.67	34.11	106.15
Non-Current Assets
Property, Plant & Equipment (Net)	29.92	34.98	41.23
Long-Term Investments	1.09	0.00	0.00
Other Non-Current Assets	7.87	2.41	2.58
Total Non-Current Assets	38.87	37.39	43.81
Total Assets	240.54	71.50	149.96
Current Liabilities
Accounts Payable	1.94	2.02	1.59
Short-Term Debt	4.63	0.00	0.00
Accrued Liabilities	14.10	2.93	14.87
Other Current Liabilities	14.10	0.00	0.00
Total Current Liabilities	20.67	16.32	20.78
Non-Current Liabilities
Long-Term Debt	22.00	20.08	27.73
Other Non-Current Liabilities	0.97	0.00	0.00
Total Non-Current Liabilities	22.97	429.04	411.63
Total Liabilities	43.64	445.35	48.51
Stockholders' Equity
Common Stock	0.00	0.00	0.02
Retained Earnings	-358.43	-395.69	-295.27
Additional Paid-in Capital	47.24	21.84	12.81
Shares Outstanding	43.78	43.78	43.78
Total Stockholders' Equity	196.90	-373.85	101.44
Total Liabilities & Equity	240.54	71.50	149.96